The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 5,998 | 25 | N/A | N/A |
| Receivables | 17,259 | N/A | N/A | N/A |
| Inventories | 4,354 | N/A | N/A | N/A |
| TOTAL | $29,720 | $25 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,104 | N/A | N/A | N/A |
| Intangibles | 33,743 | 0 | 0 | 0 |
| Other Non-Current Assets | 122 | 25 | 0 | 0 |
| TOTAL | $35,969 | $25 | $N/A | $N/A |
| Total Assets | $65,689 | $50 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 5,368 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 12,643 | 0 | 0 | 0 |
| Accrued Expenses | 9,452 | 27 | N/A | N/A |
| TOTAL | $28,607 | $27 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 6,561 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 807 | 0 | 0 | 0 |
| TOTAL | $8,981 | $N/A | $N/A | $N/A |
| Total Liabilities | $37,588 | $27 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 28,750 | N/A | N/A | N/A |
| Common Shares | 6 | 1 | N/A | N/A |
| Retained earnings | -52,307 | -2 | N/A | N/A |
| TOTAL | $28,101 | $23 | $N/A | $N/A |
| Total Liabilities And Equity | $65,689 | $50 | $0 | $0 |